| Name | Title | Contact Details |
|---|---|---|
Travis Nevels |
Director, ASCVD Marketing Strategy | Profile |
Mike Driscoll |
Regional Sales Director | Profile |
Grant Jackson |
Director, Renal Marketing Strategy | Profile |
Timothy Moody |
Associate Director, Supply Chain Planning | Profile |
Maria Rocca-Ichikawa |
Head Finance Global Drug | Profile |
Our mission at Kelyniam is to apply 3D printing and rapid prototyping technology to create innovative medical products that improve the lives of physicians and their patients.
Asembia constantly connects and strengthens the pharmaceutical industry to improve the experiences of patients everywhere.
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
Niadyne is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our AI & AR powered technology reduces medical practice overhead, accelerates patient throughput, improves efficiency, and speeds up data collection.